Investigation on the hybridoma cell requirement of glucose and glutamine concentration for growth by Saifuddin , Baharuddin
III 
 
 
 
 
 
 
 
INVESTIGATION ON THE HYBRIDOMA CELL 
REQUIREMENT OF GLUCOSE AND GLUTAMINE 
CONCENTRATION FOR GROWTH 
 
 
 
 
 
 
 
 
SAIFUDDIN BIN BAHARUDDIN 
 
 
 
 
 
 
 
 
Thesis submitted in partial fulfilment of the requirements 
for the award of the degree of 
Bachelor of Chemical Engineering (Biotechnology) 
 
 
 
 
 
 
Faculty of Chemical & Natural Resources Engineering 
UNIVERSITI MALAYSIA PAHANG 
 
JULY 2013 
 
 
 
© SAIFUDDIN BIN BAHARUDDIN (2013) 
  
VIII 
 
ABSTRACT 
A type of monoclonal antibody (MAb) has been developed to diagnose Congenital 
Adrenal Hyperplasia (CAH). This disease is due to gene effect that causes 
overproducing of androgen and can cause high mortality of new-born. In order to reduce 
the death rate of new-born’s due to this disease, large amount of research have been 
done to produce antibody that can helping the detection of this disease. This research 
will like to investigate on the hybridoma cells requirement of glucose and glutamine for 
growth rate and also the effect of the by-products to the growth rate of the cell. Previous 
study showed that the researcher uses a glucose and glutamine concentration from 2.7 – 
24 mM and 4 – 12 mM batch culture. The glucose and glutamine concentration used in 
this research were varied from 4 – 6 mM and 4 – 5.5 mM respectively. Growth, 
metabolites consumption (glucose and glutamine) and waste production (lactate and 
ammonia) were monitored. At the end of this research, the cell growth curve and the 
specific growth (µ) of each cell culture was determined with the effect of glucose and 
glutamine as well as lactate and ammonia to the growth of this hybridoma cell. From 
the results, the maximum cell density achieved at the lowest concentration of glucose 
and glutamine (4mM) was 7.85 × 10
5
 cells/mL, whereas for the highest was 13.15 × 10
5
 
cells/mL. From these results, it shows that low glucose and glutamine concentration 
could also be sufficient enough to achieve a good and stable growth of hybridoma cell. 
The maximum µ of 0.2026 h
-1
was achieved in a medium containing 6mM glucose and 
5.5mM glutamine. The glutamine was found to play a major role in the cell growth 
where it also affects the specific growth rate of the hybridoma cell. The metabolites 
were determined using YSL biochemical analyser, where it detects glucose, glutamine, 
lactate and ammonia. Due to equipment breakdown and insufficient time, the ammonia 
needs to be skipped. The glucose concentration of 6mM in the culture produces 
maximum concentration of lactate at 10.1mM. The data obtained for ɋglucose, ɋglutamine 
and ɋlactate was highest at the highest glucose and glutamine concentration (6mM and 
5.5mM) where ɋglucose and ɋglutamine were consumed and ɋlactate was produced the most. 
The glucose (ɋglucose) consumed was -0.0020 nmol/10
6
 cells.hr, glutamine (ɋglutamine) 
consumed was at -0.0018 nmol/10
6
cells.hr and lactate produced of 0.58 nmol/10
6
 
cells.hr. This shows that the feeding of high glucose was not suitable due to high lactate 
was produced. Thus, the best low concentration to be used for feeding the hybridoma 
cell was for glucose concentration of 4mM and glutamine concentration of 5.5mM. The 
result from the experiment shows that at lower glucose concentration, the specific 
production rate of lactate will decrease as the glutamine concentration increases. It 
shows that glutamine can act as a carbon source (energy) for the hybridoma cell.  
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ABSTRAK 
Sejenis antibodi monoklonal (MAb) telah di produksikan untuk mendiagnosis 
Hyperplasia adrenal kongenital (HAK). Penyakit ini adalah disebabkan oleh kesan gen 
yang menyebabkan overproducing androgen dan boleh menyebabkan kematian yang 
tinggi daripada bayi yang baru lahir. Dalam usaha untuk mengurangkan kadar kematian 
bayi yang baru lahir kerana penyakit ini, sejumlah besar penyelidikan telah dilakukan 
untuk menghasilkan antibodi yang boleh membantu mengesan penyakit ini. Kajian ini 
akan diuji untuk menyiasat keperluan sel-sel hybridoma terhadap glukosa dan glutamin 
untuk kadar pertumbuhan dan juga kesan pembuangan untuk kadar pertumbuhan sel. 
Kajian sebelum ini menunjukkan bahawa penyelidik menggunakan glukosa dan 
penumpuan glutamin 2.7 - 24 mM dan 4 - 12 mM budaya kumpulan. Glukosa dan 
penumpuan glutamin digunakan dalam kajian ini adalah berbeza-beza 4 - 6 mM dan 4 -
5.5 mM masing-masing. Pertumbuhan, penggunaan metabolit (glukosa dan glutamin) 
dan sisa pengeluaran (laktat dan ammonia) telah dipantau. Pada akhir kajian ini, keluk 
pertumbuhan sel dan pertumbuhan tertentu (μ) setiap budaya sel telah ditentukan 
dengan kesan glukosa dan glutamin serta laktat dan ammonia kepada pertumbuhan sel 
hybridoma ini. Penentuan kinetik juga telah dibangunkan untuk strategi suapan. 
Daripada keputusan, ketumpatan sel maksimum dicapai pada kepekatan yang rendah 
glukosa dan glutamin (4mM) adalah 7.85 × 10
5
 sel / mL, manakala yang tertinggi 
adalah 13.15 × 10
5
 sel / mL. Daripada keputusan ini, ia menunjukkan bahawa glukosa 
yang rendah dan kepekatan glutamin juga boleh menjadi cukup untuk mencapai 
pertumbuhan yang baik dan stabil sel hybridoma. μ maksimum telah dicapai iaitu 
0.2026 h
-1
 dalam medium yang mengandungi glukosa 6mM dan glutamin 5.5mM. 
Glutamin itu didapati memainkan peranan penting dalam pertumbuhan sel di mana ia 
juga memberi kesan kepada kadar pertumbuhan spesifik sel hybridoma itu. Metabolit 
telah ditentukan dengan menggunakan penganalisis biokimia YSL, di mana ia 
mengesan glukosa, glutamin, laktat dan ammonia. Oleh kerana kerosakan peralatan dan 
masa tidak mencukupi, ammonia perlu dilangkau. Kepekatan glukosa 6mM dalam 
budaya menghasilkan kepekatan maksimum laktat 10.1mM. Data yang diperolehi untuk 
ɋglukosa, ɋglutamin dan ɋlactate adalah tertinggi pada glukosa yang tinggi dan kepekatan 
glutamin (6mM dan 5.5mM) di mana ɋglukosa dan ɋglutamin dimakan dan ɋlactate dihasilkan 
yang paling banyak. Glukosa (ɋglukosa) yang digunakan adalah -0.0020 nmol/10
6
 sel.jam, 
glutamin (ɋglutamin) yang digunakan adalah pada -0.0018 nmol/10
6
 sel.jam dan laktat 
dihasilkan daripada 0.58 nmol/10
6
 sel.jam. Ini menunjukkan bahawa suapan glukosa 
yang tinggi tidak sesuai kerana laktat tinggi telah dihasilkan. Oleh itu, kepekatan rendah 
terbaik untuk digunakan untuk memberi makan sel hybridoma adalah dengan kepekatan 
glukosa 4mM dan penumpuan glutamin yang 5.5mM. Hasil daripada eksperimen 
menunjukkan bahawa pada kepekatan glukosa yang lebih rendah, kadar pengeluaran 
tertentu laktat akan berkurangan dengan pertambahan kepekatan glutamin. Ia 
menunjukkan glutamin yang boleh bertindak sebagai sumber karbon (tenaga) untuk sel 
hybridoma itu. 
  
X 
 
TABLE OF CONTENTS 
 
SUPERVISOR’S DECLARATION ............................................................................... IV 
STUDENT’S DECLARATION ...................................................................................... V 
DEDICATION ................................................................................................................. VI 
ACKNOWLEDGEMENT ............................................................................................. VII 
ABSTRACT ................................................................................................................. VIII 
ABSTRAK ................................................................................................................... VIII 
TABLE OF CONTENTS ................................................................................................ IX 
LIST OF FIGURES ....................................................................................................... XII 
LIST OF TABLES ....................................................................................................... XIV 
LIST OF ABBREVIATIONS ...................................................................................... XVI 
LIST OF ABBREVIATIONS ..................................................................................... XVII 
1 INTRODUCTION .................................................................................................... 1 
1.1 Background of study ............................................... Error! Bookmark not defined. 
1.2 Problem statement .............................................................................................. 1 
1.3 Objective............................................................ Error! Bookmark not defined. 
1.4 Research scope ................................................................................................... 2 
1.5 Significant of study ............................................................................................ 2 
2 LITERATURE REVIEW ......................................................................................... 4 
2.1 What is Hybridoma Cell ..................................................................................... 4 
2.2 Monoclonal Antibody ........................................................................................ 6 
2.3 Major Nutrient ...................................................................................................... 8 
 2.3.1     Glucose .................................................................................................. 8 
 2.3.2     Glutamine .............................................................................................. 9 
2.4 Waste Production ............................................................................................. 10 
 2.4.1     Lactate ................................................................................................. 10 
 2.4.2     Ammonia ............................................................................................. 11 
2.5 Congenital Adrenal Hyperplasia (CAH) .......................................................... 11 
3 MATERIALS AND METHODS ............................................................................ 14 
3.1 Maintenance Medium ....................................................................................... 15 
3.2 Growth Medium ............................................................................................... 15 
3.3 Cell culture procedure ...................................................................................... 15 
3.4 Analytical Methods .......................................................................................... 16 
 3.4.1     Cell counting ....................................................................................... 16 
 3.4.2     Metabolites Analysis ........................................................................... 17 
4 RESULTS AND DISCUSSION ................................................................................. 18 
4.1 Cell Density Determination .............................................................................. 18 
 4.1.1     Glucose Concentration ........................................................................ 18 
 4.1.2     Glutamine Concentration .................................................................... 20 
 4.1.3     The Relationship Between Glucose and Glutamine Concentration in  
             Hybridoma Cell Growth ....................................................................... 22 
 4.1.4     Specific Growth Rate (µ) .................................................................... 23 
4.2 Metabolic Analysis ........................................................................................... 25 
4.3 Relationship between Growth Rate of Cell and Nutrients Consumption and byproduct 
 Production .......................................................................................................... 29 
 
5 CONCLUSION AND RECOMMENDATION ...................................................... 31 
XI 
 
5.1 Conclusion........................................................................................................ 31 
5.2 Recommendation ................................................................................................ 31 
REFERENCES ............................................................................................................... 32 
APPENDICES ................................................................................................................ 34 
 
  
XII 
 
LIST OF FIGURES 
 
Figure 1-1: The metabolites profile of hybridoma cell (mouse spleen and mouse 
myeloma cell) growth and production of monoclonal antibody by Ozturk and Palsson 
(1990) ................................................................................................................. 2 
Figure 2-1: Spleen cells used for hybrid by Tyagi et al. (2011) .................................. 4 
Figure 2-2: Myeloma cells used for hybrid by Tyagi et al. (2011) .............................. 4 
Figure 2-3: Combination of myeloma cell and mammalian cell (hybridoma cell) by 
Tyagi et al. (2011) ................................................................................................ 5 
Figure 2-4: The principles of hybridoma production via mouse spleen and myeloma cell 
by Hayter. (1989) ................................................................................................. 6 
Figure 2-5: The sequence of production of monoclonal antibody by Ethan and Lerner 
(1981) ................................................................................................................. 7 
Figure 2-6: The adrenal glands which causes the CAH disease by Stresing (2011) ..... 12 
Figure 3-1: The overall methodology for the experiment ......................................... 14 
Figure 3-2: Haemocytometer grid lines  ................................................................ 16 
Figure 4-1: Comparison of glucose from 4mM to 6mM concentrations for glutamine of 
4mM ................................................................................................................. 19 
Figure 4-2: Comparison of glutamine from 4mM to 5.5mM concentrations for glucose 
of 4mM ............................................................................................................. 21 
Figure 4-3: Specific Growth Rate (µm) for Glutamine constant from 4mM to 5.5mM and 
Glucose varies from 4mM to 6mM concentration ................................................... 24 
Figure 4-4: Specific Growth Rate (µm) for Glucose constant from 4mM to 6mM and 
Glutamine varies from 4mM to 5.5mM concentration ............................................. 24 
Figure 4-5: Metabolites profile of hybridoma cells ................................................. 27 
Figure 4-6: Relationship of low glucose and glutamine concentration with metabolites
 ......................................................................................................................... 30 
Figure 4-7: Relationship of high glucose and glutamine concentration with metabolites
 ......................................................................................................................... 30 
Figure A-1: Cell growth curve for glucose varying from 4mM to 6mM at constant 
glutamine concentration of 4.5mM ....................................................................... 35 
Figure A-2: Cell growth curve for glucose varying from 4mM to 6mM at constant 
glutamine concentration of 5mM .......................................................................... 36 
Figure A-3: Cell growth curve for glucose varying from 4mM to 6mM at constant 
glutamine concentration of 5.5mM ....................................................................... 36 
Figure A-4: Cell growth curve for glutamine varying from 4mM to 5.5mM at constant 
glucose concentration of 4.5mM ........................................................................... 39 
Figure A-5: Cell growth curve for glutamine varying from 4mM to 5.5mM at constant 
glucose concentration of 5mM ............................................................................. 39 
Figure A-6: Cell growth curve for glutamine varying from 4mM to 5.5mM at constant 
glucose concentration of 5.5mM ........................................................................... 40 
XIII 
 
Figure A-7: Cell growth curve for glutamine varying from 4mM to 5.5mM at constant 
glucose concentration of 6mM ............................................................................. 40 
XIV 
 
LIST OF TABLES 
 
Table 4-1: Cell density data for the glucose from 4 to 6mM with glutamine of 4mM . 19 
Table 4-2: Cell density data for the glutamine from 4 to 5.5mM with glucose of 4mM .... 
 ......................................................................................................................... 20 
Table 4-3: Data for each glucose and glutamine with their maximum cell density ...... 23 
Table 4-4: The Specific Growth Rate (µ) for each data of glucose and glutamine .........23 
Table 4-5: The Nutrients (glucose and glutamine) consumption and the by-products 
(lactate) at glucose and glutamine concentration of 4mM ..................................................26 
Table 4-6: Specific Consumption and Production (byproduct) rate for Glutamine 
concentration of 4mM to 5.5mM and Glucose concentration of 4mM to 6mM (negative 
{-} sign means cell death) .......................................................................................................28 
Table A-1: Cell Density for glucose varying from 4mM to 6mM at constant glutamine 
concentration of 4.5mM ..........................................................................................................34 
Table A-2: Cell Density for glucose varying from 4mM to 6mM at constant glutamine 
concentration of 5mM ..............................................................................................................34 
Table A-3: Cell Density for glucose varying from 4mM to 6mM at constant glutamine 
concentration of 5.5mM ..........................................................................................................35 
Table A-4: Cell Density for glutamine varying from 4mM to 5.5mM at constant 
glutamine concentration of 4.5mM ........................................................................................37 
Table A-5: Cell Density for glutamine varying from 4mM to 5.5mM at constant 
glutamine concentration of 5mM ...........................................................................................37 
Table A-6: Cell Density for glutamine varying from 4mM to 5.5mM at constant 
glutamine concentration of 5.5mM ........................................................................................38 
Table A-7: Cell Density for glutamine varying from 4mM to 5.5mM at constant 
glutamine concentration of 6mM ...........................................................................................38 
Table B-1: Overall Data for the Glucose and Glutamine Concentration of 4mM ...........41 
Table B-2: Overall Data for the Glucose and Glutamine Concentration of 4.5mM and 
4mM ...........................................................................................................................................41 
Table B-3: Overall Data for the Glucose and Glutamine Concentration of 5mM and 
4mM ...........................................................................................................................................42 
Table B-4: Overall Data for the Glucose and Glutamine Concentration of 5.5mM and 
4mM ...........................................................................................................................................42 
Table B-5: Overall Data for the Glucose and Glutamine Concentration of 6mM and 
4mM ...........................................................................................................................................43 
Table B-6: Overall Data for the Glucose and Glutamine Concentration of 4mM and 
4.5mM ........................................................................................................................................43 
Table B-7: Overall Data for the Glucose and Glutamine Concentration of 4.5mM and 
4.5mM ........................................................................................................................................44 
Table B-8: Overall Data for the Glucose and Glutamine Concentration of 5mM and 
4.5mM ........................................................................................................................................44 
XV 
 
Table B-9: Overall Data for the Glucose and Glutamine Concentration of 5.5mM and 
4.5mM ........................................................................................................................................45 
Table B-10: Overall Data for the Glucose and Glutamine Concentration of 6mM and 
4.5mM ........................................................................................................................................45 
Table B-11: Overall Data for the Glucose and Glutamine Concentration of 4mM and 
5mM ...........................................................................................................................................46 
Table B-12: Overall Data for the Glucose and Glutamine Concentration of 4.5mM and 
5mM ...........................................................................................................................................46 
Table B-13: Overall Data for the Glucose and Glutamine Concentration of 5mM and 
5mM ...........................................................................................................................................47 
Table B-14: Overall Data for the Glucose and Glutamine Concentration of 5.5mM and 
5mM ...........................................................................................................................................47 
Table B-15: Overall Data for the Glucose and Glutamine Concentration of 6mM and 
5mM ...........................................................................................................................................48 
Table B-16: Overall Data for the Glucose and Glutamine Concentration of 4mM and 
5.5mM ........................................................................................................................................48 
Table B-17: Overall Data for the Glucose and Glutamine Concentration of 4.5mM and 
5.5mM ........................................................................................................................................49 
Table B-18: Overall Data for the Glucose and Glutamine Concentration of 5mM and 
5.5mM ........................................................................................................................................49 
Table B-19: Overall Data for the Glucose and Glutamine Concentration of 5.5mM and 
5.5mM ........................................................................................................................................50 
Table B-20: Overall Data for the Glucose and Glutamine Concentration of 6mM and 
5.5mM ........................................................................................................................................50 
Table B-21: Overall Data for the Baseline ............................................................................51 
Table B-22: Data for µ and ɋglucose, ɋglutamine, and ɋlactate for all glucose and glutamine 
concentration .............................................................................................................................51 
 
 
 
 
  
XVI 
 
LIST OF ABBREVIATIONS 
 
mg/L concentration (milligram per litre)
 
µm
 Size of filter (micrometre) 
mM concentration (milliMolar) 
mL volume of water (millilitre) 
L volume of water (litre) 
v/v Volume per volume 
% Percentage 
o
C Temperature (degree Celsius) 
CO2 Carbon Dioxide 
µL volume of water (microliter) 
NT Total no of cell 
NV  no of viable cell 
ɋglucose Consumption rate of glucose concentration 
ɋglutamine Consumption rate of glutamine concentration 
ɋlactate Production rate of lactate concentration  
 
Subscripts 
G gravity 
min minutes 
hr/ h hour 
d days 
< less then 
 
  
XVII 
 
LIST OF ABBREVIATIONS 
 
ACTH  Adrenocortocotropic 
21OHD 21-hydroxylase deficiency 
CRH  Corticotropin-releasing hormone 
CAH  Congenital Adrenal Hyperplasia 
ERK  Extracellular signal-regulated kinase  
JNK  c-Jun-terminal kinase 
PKA  cAMP-activated protein kinase 
AHA  Alpha hydroxyl acid 
LDH  Enzyme lactate dehydrogenase 
MAb  Monoclonal Antibody 
DMEM Dulbecco’s Modified Eagle’s Medium 
ATP  Adenosine 5'-triphosphate  
 1 
 
1 INTRODUCTION 
 
1.1 Background of study 
Congenital Adrenal Hyperplasia (CAH) is a disease that can occur in adults or newborn babies. It 
can be caused by either family inheritance or by the over secretion of the corticotropin-releasing 
hormone (CRH), adrenocortocotropic hormone (ACTH) and hyperplasia of adrenal glands. The 
main reasons is the defect of enzyme 21-hydroxylase (21-hydroxylase deficiency [21OHD]). It 
has been reported that more than 90% (Antal and Zhou, 2009) up to 95% (National Institute of 
Health Clinic Center (NIHCC), 2004) of CAH disease was caused by this defect. This disease 
can happen in both male and female, but for female the disease can detect easily. This is due to 
the formation of penis at their clitoris because of excessive excretion of androgen. For the male, 
the newborn have no obvious visual symptoms but as they grow older mainly 2 to 3 years old, 
they start to become muscular, experience penis growth, pubic hair development and deepening 
voice occurred (Stresing, 2011). The most severe CAH can lead to death. This is due to the 
dehydration and low blood pressure of patient that affected by this disease (National Institute of 
Health Clinic Center (NIHCC), 2004). To solve this disease and death problem, an antibody was 
created in order to detect the CAH disease. This antibody is produced from a merge between 
mouse myeloma cell and mouse spleen cell in which to develop hybridoma cell. This hybridoma 
cell is a long lasting cell that can help in the production of the required antibodies. In order to 
improve the antibody production, the nutrients requirement must be known for this hybridoma 
cell to achieve a good growth rate and to know the byproduct (wastes) build up in the cell 
medium. These nutrients (glucose and glutamine) will ensure the growth of cell is at good 
condition whereas the byproducts (lactate and ammonia) will show the disturbance to the cell 
growth. 
 
1.2 Problem Statement 
One type of cell can produce this antibody for the detection of 17α-hydroxyprogesterone, which 
is overproducing due to deficiency of 21OHD. This cell is known as hybridoma cell. In order to 
know the cell growth, the glucose and glutamine concentration has been determined to achieve 
the high yield of this antibody. It is known that the byproduct being produced also effect the cell 
growth. The problem with the hybridoma cell is that it cannot grow well under low and high 
concentration of glucose and glutamine due to the production of byproducts of the cell. This cell 
 2 
 
growth can be affected by the byproducts production in a fed batch scale method due to the 
medium containing the byproducts cannot be removed. Therefore, the cell growth of the 
hybridoma cell can be improved by using batch method. However, the right time and right 
amount of nutrient must be fed to sustain growth and increase growth rate. This can only be done 
if the metabolites of this hybridoma cells are determined.  
 
1.3 Objective 
The objective of this study is to investigate the hybridoma cells requirement of glucose and 
glutamine for cell growth and the effects of byproducts to the growth metabolism.  
 
1.4 Research Scope 
In order to achieve the sole objective of this research, few scopes have been determined: 
1. To identify the concentration of glucose and glutamine needed for hybridoma in order to 
maintain cell growth at optimum condition. 
2. To identify the effects of byproducts to the growth of the hybridoma cell 
 
1.5 Significant of Studies 
This study is significant in determining the hybridoma cell characteristics. By knowing the 
profiles of the metabolites such as glucose, glutamine, lactate and ammonia for this hybridoma 
cell, the kinetic model can be developed. These metabolites typical consumption or production 
trends are presented in the Figure 1.1 (Ozturk and Palsson, 1990).  
 
 
Figure 1-1: The metabolites profile of hybridoma cell (mouse spleen and mouse myeloma cell) 
growth and production of monoclonal antibody of a researcher (Ozturk and Palsson, 1990) 
  
 3 
 
This kinetic model can be used to develop a feeding strategies for fed-batch or continuous 
culture in the hybridoma cell in order to achieve the highest cell growth in order to produce the 
antibody at maximum condition. 
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2 LITERATURE REVIEW 
 
2.1 What is Hybridoma Cell? 
Hybridoma cell is a hybrid cell line that was formed by combining two kinds of cells that are 
spleen cell (B-cell) of a mammalian and myeloma cell. Myeloma cell is a cell that was taken 
from a tumor at the bone marrow where cancerous cell were formed (Tyagi et al., 2011), whereas 
the B-cell is a B-lymphocyte which secretes antibody. The fusion of both these cells will achieve 
an antibody production cell which it will be long lasting (immortality) than without the hybrid 
(Hayter, 1989). Figures 2.1, 2.2, and 2.3 show the example of spleen cells used for hybrid, 
myeloma cells used for hybrid and the combination of myeloma cell and spleen cell to form 
hybridoma cell.  
 
Figure 2-1: Spleen cells used for hybrid (Tyagi et al., 2011) 
 
Figure 2-2: Myeloma cells used for hybrid (Tyagi et al., 2011) 
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Figure 2-3: Combination of myeloma cell and mammalian cell (hybridoma cell) (Tyagi et al., 
2011) 
 
In order to achieve the hybridoma that secretes the desired antibody, an animal (usually a mouse) 
is being immunized with the required antigen by using in vitro immunization technique. The 
spleen of the animal is then being harvested in order to get the B-lymphocytes which are then 
fused with the myeloma cell which we obtained from a cancer cell. Based on Hayter (1989), the 
B-cell obtained from the mouse spleen is then merging with the cultured myeloma cell to get the 
hybrid cell. Figure 2.4 shows the principles of hybridoma production via mouse spleen and 
myeloma cell (Hayter, 1989). 
 6 
 
 
Figure 2-4: The principles of hybridoma production via mouse spleen and myeloma cell 
(Hayter, 1989) 
 
2.2 Monoclonal Antibody 
The term monoclonal means a single clone cells. The antibodies that produced by a single clone 
cells are called monoclonal antibodies. The content in the system of producing antibodies is B 
cells. The B cells follows an antigenic stimulation proliferate that gives clone cells the capability 
to produce homologous antibodies with a paratope that can bind with the epitope of antigen 
responsible for its creation. Since a single antigen possesses number of epitopes, it can initiate 
proliferation and differentiation of a variety of B cell clones in the system. In return, the 
production of heterogenous group of antibodies in normal conditions was achieved.  
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Since monoclonal antibody is produced by identical immune cells or clones, they have 
monovalent affinity that they bind to the same epitope. The epitope is known as antigenic 
determinant, which the part of an antigen that is recognized by the immune system, specifically 
by antibodies, B cells, or T cells. Monoclonal antibody can function to bind with other 
substances in which the purposes are to detect or purify the substances. Figure 2.5 shows the 
sequence of production of monoclonal antibody. 
 
Figure 2-5: The sequence of production of monoclonal antibody (Ethan & Lerner, 1981) 
 
Monoclonal antibody is currently the most demanding product in pharmaceutical industries due 
to it is the main ingredient in producing the medical treatment. Since this antibody can also serve 
as detection to certain diseases, this antibody has been used as diagnostic substances to identify 
the disease. This antibody can be used in treatments such as therapeutic cancer treatment, drug 
abuse treatment, and others.  
 
For therapeutic treatment, the usage of this antibody is to help in reducing and destroying the 
disease inside the body. In 1975, a modern era therapy for cancer was launched due to the 
antibody was discovered by Kohler and Milstein. The antibody is used for therapy because of its 
ability to bind specifically to primary and metastatic cancer cells with high affinity and create 
antitumor effect by complement-meditated cytolysis and antibody-dependent or by focused 
delivery of radiation to the cancer cells (Ross et al., 2003). For cancer treatment, the antibody has 
the ability to destroy the tumor or cancerous cell. The ability of this antibody enhanced the 
antitumor effects of chemotherapy and radiotherapy in preclinical models by inhibiting cell 
proliferation, angiogenesis, and metastasis and by promoting apoptosis (Ross et al., 2003). 
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For drug abuse treatment, the monoclonal antibody medications have the ability to preselect the 
affinity and specificity of the drug, and thereby have the medication parameters been constant 
from one kind of drug to another. It also has the ability to give an immediate protection to the 
drug abuse person (Peterson et al., 2006). Thus, this MAb can be used for curing drug addiction.  
 
The monoclonal antibody is required in large amount in order to reduce the number of diseases 
affected people. Large scale production means that the byproducts will be increased. Since 
byproducts are one of the main causes for cell death, thus the nutrient requirements need to be 
controlled.  
 
2.3 Major Nutrient 
 
2.3.1 Glucose 
Glucose is one of the most important carbohydrates that required by all living cell. Carbohydrate 
is an organic that consists of the main important molecule inside living things, for example 
carbon, hydrogen and oxygen. Glucose is a main compound that needed inside the cell in order 
to give energy and it is important for the metabolism of the cell (Siegwart et al., 1999). It is 
required in order to make the cell live longer and healthier so it can give a well-developed 
product. Hybridoma cell is one of the cells that require a lot of glucose in order to grow in stable 
condition and give high yield of products (Xie and Wang, 1996). Hybridoma cell need glucose 
for the metabolism and reproduction of the cell but if the glucose is too high, the cell will 
eventually die due to the inhibition of waste products (lactic acid). If the concentration is too 
low, the cell cannot reproduce in a good condition. Thus, maintaining the glucose concentration 
at a sufficient level is required. Based on Siegwart et al (1999), glucose was fed at low level to 
the hybridoma cell. The concentration used was between 1.1-5.5 mM, where this concentration 
can redirects the metabolism of the hybridoma cell to a reduction of glucose uptake rate and 
lactic acid production rate in batch bioreactor (Siegwart et al., 1999). The purpose of study by 
Siegwart et al. (1999) was to determine the glucose effect towards the growth of hybridoma cell 
and production of monoclonal antibody. They found that the yield of hybridoma cell density 
decrease slightly as the glucose supply and consumption increases. In another research, a lower 
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concentration of glucose supply was being used that was 0.5mM in a fed batch scale (Xie and 
Wang, 1996). The low concentration supply of glucose is for the condition so that the hybridoma 
cell can grow in good condition for batch scale. Based on other research from Lee (2002), the 
glucose concentration used is 2.7mM to 24mM, where good growth curve and antibody 
production of the cell by using the batch method was obtained. Xie and Wang (1996) found that 
glucose was not the only nutrient or supplement that can cause the decrement in production rate, 
other supplement such as glutamine also affects the production. 
 
2.3.2 Glutamine  
Glutamine is amino acids that are the building blocks of the cell. It is not only for protein 
production but also a compound that influenced several cellular signaling pathways inside the 
cell including extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), 
the cAMP-activated protein kinase (PKA) (Xia et al., 2003) and the mammalian target of 
rapamycin(mTOR) pathways (Xia et al., 2003). This compound is also involved in gene 
expression control (Abcouwer et al., 1999; Huang et al., 1999; Wischmeyer, 2002) where it is 
needed to modulate the activity of the ubiquitin-proteasome protein degradation pathway 
(Paquette et al., 2005). This compound is also involved in the proliferation and the survival of 
hybridoma cell. Since glutamine is also one of the important intake of this cell, the concentration 
of the glutamine need to be identified. High concentration of glutamine will result in the higher 
ammonia production.  High ammonia concentration causes the cell cannot live healthy since 
ammonia is toxic to cell. Low concentration of glutamine causes the cell to reduce in growth rate 
and eventually die. Thus, maintaining the required glutamine is essential. The glutamine 
concentration of 0.2mM was fed continuously to the cell culture in the study of Xie and Wang 
(1996). The cell density was found to increase from 6.5-7.5 x 10
6
 cells/mL to 1.7 x 10
7
 cells/mL 
(Xie and Wang, 1996). Based on another researcher (Li et al., 2005), two concentration of 
glutamine, 0.5-4mM and 0.5-2mM were continuously fed to the reactor. This researcher found 
that glutamine was totally consumed by both NORIg 7.16.2 hybridoma cell lines. The production 
of ammonia from the first concentration of glutamine (0.5-4mM) was much higher than the 
second concentration (0.5 – 2mM) of glutamine supply (Li et al., 2005). Other than that, Lee 
(2002) observed that at these concentrations (4mM to 12mM) of glutamine, a good growth curve 
can be obtained as well as a good antibody production. This shows that glutamine is essential in 
the growth of hybridoma cell.  
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2.4 Waste production 
 
2.4.1 Lactate 
Lactate or lactic acid is a chemical compound that plays role in various biochemical processes. 
Lactic acid is a carboxylic acid that has a hydroxyl group adjacent to carboxyl group making it a 
alpha hydroxyl acid (AHA). In animal cells, L-lactate is constantly produced from pyruvate via 
the enzyme lactate dehydrogenase (LDH). The process that produce this lactate is fermentation 
which during normal metabolism and exercise. The lactate concentration does not increase in 
concentration until the rate of lactate production exceeds the rate of lactate removal. This process 
is governed by a number of factors, including monocarboxylate transporters, concentration and 
isoform of LDH, and oxidative capacity of tissues. The factor that increases the lactate 
concentration is due to the exceeding of glucose consumption. The higher the glucose 
consumption will increase the lactate production. The production rate of lactate in a research 
article of Xie and Wang (1996) was 4.2mM. Since this was considered as low lactate production, 
the conversion of glucose to lactate was only 3.4% (Xie and Wang, 1996). This is because the 
consumption of glucose was only 0.5mM. Thus the lactate production was not so high and this 
can cause only little effect to the hybridoma cell. Lee (2002) stated that the increase of glucose 
will increase the lactate production, where his research shows that the lactate concentration 
increases from 0mM to 30mM as the concentration of glucose added into the culture increases 
from 2.7mM to 24mM. Since the growth metabolism was affected by the high concentration of 
inhibitor (lactate), higher glucose consumption resultant in faster inhibition to take place. 
Therefore, lactate is a byproduct from glucose consumption and causes the inhibition towards the 
cell growth but lactate will not give a toxicity effect. This shows that reduction of initial glucose 
concentration produce only little lactate byproducts. 
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2.4.2 Ammonia 
Ammonia is a compound of nitrogen and hydrogen. It is a colorless gas with a characteristic 
pungent odor. Ammonia contributes significantly to the nutritional needs of terrestrial organisms 
by serving as a precursor to food and fertilizers. Ammonia is a chemical compound that has 
benefits to living things but if it exceeds the maximum amount, it will become toxic inside living 
cell. For hybridoma cell, high concentration of ammonia can cause the cell to become toxic and 
finally the cell will die due to too toxic. Ammonia is the reasons why hybridomas become toxic 
at the late growth of the cell (Miller et al., 1987). In order to decrease the ammonia production, 
the glutamine consumption needs to be lower. From a research article, the ammonia production 
rate was 5.6mM which is 38% lower than the previous studies of ammonia production (Xie and 
Wang, 1996). This is because the consumption of glutamine was only 0.2mM and this will 
produce only little ammonia. From another research journal, the production rate of ammonia 
increases due to the consumption of glutamine was high (4mM) (Li et al., 2005). Other than that, 
Lee (2002) observed that the ammonia production was from 0mM to 15mM as the glutamine 
concentration increases from initial concentration of 4mM to 12mM. This researcher stated that 
the high ammonia concentration can lead to the death of the cell due to the toxicity and it also 
affect greatly to the cell growth and the antibody production. Thus the concentration of ammonia 
production increases as the glutamine consumption increases. 
 
2.5 Congenital Adrenal Hyperplasia (CAH) 
Congenital Adrenal Hyperplasia (CAH) refers to a family of inherited disorders of adrenal 
steroidogenesis. The cause of this disease is due to the impaired cortisol secretion in which the 
hypersecretion of corticotropin-releasing hormone (CRH), adrenocortocotropic hormone 
(ACTH) and hyperplasia of adrenal glands. There are two types of CAH disease which the 
severe form called classic CAH while the mild form is called nonclassic CAH. The most 
common cases of CAH disease are caused by defect in the enzyme 21-hydroxylase (21-
hydroxylase deficiency [21OHD]) and has been reported that more than 90% (Antal and Zhou, 
2009) up to 95% (National Institute of Health Clinic Center (NIHCC), 2004) CAH diseases was 
caused by this defect. This CAH is also a several autosomal recessive diseases resulting from 
mutations of genes for the biochemical steps in producing cortisol from cholesterol by adrenal 
glands. Figure 2.6 shows the adrenal glands which causes the CAH disease. 
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Figure 2-6: The adrenal glands which causes the CAH disease (Stresing, 2011) 
 
A child with this type of CAH disease has adrenal glands that cannot make enough cortisol and 
may or may not make aldosterone. As a result, the glands over-work trying to make these 
hormones and end up making too much of what they can make which is androgens. For example, 
a girl that has this disease tends to be masculinized and the clitoris resembles a penis due to the 
excretion of excessive androgen by the adrenal gland during prenatal development. In newborn 
boys, there are no obvious visual symptoms but as they grow older mainly 2 to 3 years old, they 
start to become muscular, experience penis growth, pubic hair development and deepening voice 
occurred (Stresing, 2011). The second most common form of CAH is 11-hydroxylase deficiency. 
A child with this type of CAH has adrenal glands that make too much androgen and not enough 
cortisol. Children with this type of CAH may also have high blood pressure. These patients do 
not have aldosterone deficiency (National Institute of Health Clinic Center (NIHCC), 2004). 
Other than that, the non-classical CAH has one type of deficiency which is 21-hydroxylase 
deficiency. People with this deficiency make enough cortisol and aldosterone, but they make 
excess androgens. Symptoms come and go, beginning at any time but typically in late childhood 
or early adulthood. Boys often do not need treatment. Girls usually need treatment to suppress 
their excess androgens. This disease is quite dangerous if leave untreated. The cause can be a 
severe damage to them as they grow older. This is because other diseases can occur such as 
respiratory illness and infections that are very hard to cure, high blood pressure with low blood 
 13 
 
potassium, poor feeding and vomiting, failure to gain weight, short stature and severe acne 
(Stresing, 2011). Other than that, the CAH causes the pituitary adrenocorticotrophic hormone 
(ACTH) to overproduce and thus the metabolic abnormalities increases. This effect will increase 
the salt development inside the infant body causes the body to quickly dehydrate and lastly can 
lead to death. As such early diagnosing ensures the preventive treatment can be carried out to the 
patient.  
 
  
